Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Category Archives: Cell Medicine
Two stem cell therapies from Cytomedix to start trials; stroke study expands
When regenerative medicine firm Cytomedix (OTC:CMXI) acquired biotechnology company Aldagen, the stem cell-based stroke treatment in clinical trials was the centerpiece of the all stock deal. Cytomedix is now making making moves to develop other stem cell treatments from its Aldagen acquisition. Continue reading
Posted in Cell Medicine
Tagged aldagen, centerpiece, clinical-trials, cytomedix-, indications, stem, summer, the-indications, told-analysts, ultimately-find
Comments Off
Death of a Cell Transplantation Pioneer Dr. Julio C. Voltarelli
Dr. Julio C. Voltarelli, who made a significant impact in cell transplantation, dies at 63 Distinguished Brazilian professor pioneered bone marrow transplantation Newswise Tampa, Fla Continue reading
Posted in Cell Medicine
Tagged brazil, medicine, research, ribeiro, ribeiro-preto, science, taiwan, technology, university
Comments Off
Navigating the IP Minefield of Human Embryonic Stem Cell Development
FARMINGTON, Conn., May 8, 2012 /PRNewswire-iReach/ — Global Information Inc. is pleased to announce two significant new reports Opportunities in Human Embryonic Stem Cell (hESC) ProductsHuman embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, the stage reached 4 to 5 days after fertilization Continue reading
Posted in Cell Medicine
Tagged a-direct-link, a-free-sample, analysis-, blood-industry, business, human-embryonic, korea, opportunities, report, singapore, university, world
Comments Off
Single cell triggers fibroid uterine tumor
CHICAGO, May 5 (UPI) — U.S. Continue reading
Posted in Cell Medicine
Tagged a-mutation-and, a-new-direction, activates-other, bulun, cells, feinberg-school, medicine, mutation, said-the-single, said-the-stem, serdar-bulun, uterine-fibroid
Comments Off
University of Miami’s Interdisciplinary Stem Cell Institute Awarded $10 Million Grant from Starr Foundation
MIAMI–(BUSINESS WIRE)– The University of Miami Miller School of Medicines Interdisciplinary Stem Cell Institute (ISCI) today announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States. The grant will support ISCI in broadening its preclinical and clinical research on stem cells, and help accelerate its pipeline of translational research and programs for a wide range of debilitating conditions including cardiac disease, cancer, wound healing, stroke, glaucoma and chronic kidney and gastrointestinal diseases. Continue reading
Posted in Cell Medicine
Tagged chief-executive, grant, medical-, medical-affairs, medicine, miami, miller-, miller-school, philanthropic, president, recognition, school, starr, united-states, university
Comments Off
Fibrocell Science Technology Leads to Discovery of Two Rare Adult Stem Cell-Like Subpopulations in Human Skin
EXTON, Pa.–(BUSINESS WIRE)– In collaboration with Fibrocell Science, Inc., (OTCBB:FCSC.OB), researchers at the University of California, Los Angeles (UCLA) have identified two rare adult stem cell-like subpopulations in adult human skin, a discovery that may yield further ground-breaking research in the field of personalized medicine for a broad range of diseases. Using technology developed by Fibrocell Science, Inc. the researchers were able to confirm the existence of these two types of cells in human skin cell cultures, potentially providing a source of stem cell-like subpopulations from skin biopsies, which are quicker to perform, relatively painless and less invasive than bone marrow and adipose tissue extractions, which are the current methods for deriving adult stem cells for patient-specific cellular therapies. Continue reading
Posted in Cell Medicine
Tagged california-, fibrocell, identification, method, regenerative, research, skin, the-researchers, ucla, university, within-the-skin
Comments Off
Genetically Modified T Cell Therapy Shown to be Safe, Lasting in Decade-Long Penn Medicine Study of HIV Patients
PHILADELPHIA HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. Continue reading
Posted in Cell Medicine
Tagged a-framework-for, a-rationale-for, a-wide-variety, bodies, earlier, hiv, laboratory, medicine, modified, science, the-modified, treatment, university, virus
Comments Off
OTTR™ Chronic Care Solutions Launches OTTRbmt™ – Pediatric Bone Marrow Stem Cell Transplant (BMT) Patient Management …
Omaha, NE (PRWEB) April 28, 2012 OTTR Chronic Care Solutions, an Omaha-based clinical process management and informatics company, recently announced the launch of its new OTTRbmt Pediatric Bone Marrow Stem Cell Transplant Patient Management System. According to CEO Lou Halperin, This Pediatric enhancement to our OTTRbmt solution is the next step in OTTR Chronic Care Solutions commitment to improving pediatric patient care and physician acceptance in the field of bone marrow stem cell transplant medicine. OTTRbmt Pediatric Bone Marrow Stem Cell Transplant Patient Management System extends the standard bone marrow stem cell transplant management system, which currently services the adult demographic. Continue reading
Posted in Cell Medicine
Tagged and-recipient, children, develops-unique, healthcare, kids, management, marrow, marrow-stem, medical-, pediatric, pediatric-bone, premier-product, transplant-, with-the-kids
Comments Off
BioTimes Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen® Product Development
BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTimes subsidiary Cell Cure Neurosciences, Ltd. Continue reading
Posted in Cell Medicine
Tagged a-treatment-and, california-, developmental, international, israel, manufacturing, nature, results, south-korea, widely-believed
Comments Off
BioTime’s Subsidiary Cell Cure Neurosciences, Ltd. Provides Update on OpRegen® Product Development
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTimes subsidiary Cell Cure Neurosciences, Ltd. Continue reading
Posted in Cell Medicine
Tagged a-blood-plasma, business, california-, development, manufacturing, pharmaceutical, south-korea, widely-believed
Comments Off
QualityStocks News – Advance Cell Technology Completes Treatment of Third Dry AMD Patient in Phase I/II Clinical Trial
Scottsdale, Arizona (PRWEB) April 21, 2012 QualityStocks would like to highlight Advanced Cell Technology, Inc., a publicly traded biotechnology company applying cellular technology in the field of regenerative medicine. ACT specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. Continue reading
Posted in Cell Medicine
Tagged advanced-cell, appropriate, clinical, development, europe, medicine, procedures, proprietary, school, steven-schwartz, successful, team, technology, treated-at-ucla, trials-
Comments Off
Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
Public release date: 17-Apr-2012 [ | E-mail | Share ] Contact: David Eve celltransplantation@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (April Continue reading
Posted in Cell Medicine
Tagged a-recent-issue, a-spinal-cord, and-co-authors, brain-repair, medicine, spinal, study, transplanted
Comments Off
Inform Genomics Announces Results of Study Predicting Risk of Oral Mucositis in Patients Undergoing High Dose …
BOSTON–(BUSINESS WIRE)– Inform Genomics, Inc., a private company focused on developing novel platforms of personalized medicine products for cancer supportive care and inflammatory diseases, today announced the completion of the first phase of product development to predict a patients risk of developing oral mucositis after receiving high dose chemotherapy prior to hematopoietic stem cell transplant. Continue reading
Posted in Cell Medicine
Tagged boston, chicago-, development, health, inform-genomics, medicine, president, professor, receiver, swedish
Comments Off
Stem cell institute to work with foreign agencies
California’s $3 billion stem cell agency, now more than 7 years old, has joined research partnerships with science and health agencies in eight foreign countries, the San Francisco institute announced. The agreements call for collaboration in efforts aimed at speeding stem cell research from the laboratory to the hospital, where researchers hope that basic human cells will be programmed to treat scores of human degenerative diseases. Continue reading
Posted in Cell Medicine
Tagged a-have-strong, argentina, article, australia, brazil, britain, china, create-exciting, japan, laboratory, spokesman-said-, state
Comments Off
Vatican’s Stem-Cell Censorship Sham
The Catholic Church has never had a particularly easy relationship with science. Continue reading
Posted in Cell Medicine
Tagged a-major-blunder, a-major-gamble-, a-tragic-mutual, biology, california-, church, congress, daily-beast-, field, service, source, universe
Comments Off
Basketball’s influence on stem cell treatments in sports medicine
As the basketball frenzy that accompanies March Madness draws to the fever pitch of the Final Four, it brings to mind that basketball is a high contact sport. Continue reading
Posted in Cell Medicine
Tagged cell-treatments, conversion, development, financial-, japan, press, sports, united, united-states, usa
Comments Off
Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation
NEW YORK, NY–(Marketwire -03/28/12)- Biotechnology stocks have been on an impressive run this year as favorable legislation out of Washington is allowing biotech companies of all sizes to more easily navigate regulations. Continue reading
Posted in Cell Medicine
Tagged a-press-release, advanced-cell, business, development, easily-navigate, health, house, independent, jumpstart, nasdaq, outlook, press-release, securities, technology
Comments Off
Vatican Calls Off Stem-Cell Conference
Nature | Health A Monsignor and Officer for Studies at the Pontifical Academy for Life called the cancellation a “sad event.” Attendees are set to receive an official explanation March 26, 2012| By Ewen Callaway of Nature magazine The Vatican has abruptly cancelled a controversial stem-cell conference that was set to be attended by the Pope next month. The Third International Congress on Responsible Stem Cell Research, scheduled for 25-28 April, was to focus on clinical applications of adult and reprogrammed stem cells. Continue reading
Posted in Cell Medicine
Tagged california-, catholic, catholic-news, children, conference, congress, embryonic-stem, european, health, massachusetts, research, the-conference
Comments Off
Proposition 71 stem cell research funds drying up
SACRAMENTO (KABC) — Eight years ago voters agreed to fund California’s stem cell agency, hoping it would yield new treatments for various conditions. Now the agency is running out of funds and any practical cures are still years away Continue reading
Posted in Cell Medicine
Tagged a-crucial-stage, agency, breakthroughs, california-, effective-until, regenerative, stem-cell, treatment
Comments Off